# HAEMONETICS CORPORATION (HAE) FY2027 Q1 Balance Sheet

- Company: HAEMONETICS CORPORATION (HAE)
- Period: As of 2026-06-27
- Filing: Q1 FY2027 10-Q, filed 2026-08-06, accession number 0000313143-26-000120
- Page: https://plicit.ai/financials/hae/fy2027-q1-balance-sheet
- Chart image: https://plicit.ai/charts/hae-fy2027-q1-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-27. The chart shows assets, liabilities and equity at that date.

- **Assets**: 2,365,400,000 US dollars
- **Current assets**: 810,832,000 US dollars
- **Non-current assets**: 1,554,568,000 US dollars
- **Liabilities (calculated)**: 1,528,299,000 US dollars
- **Current liabilities**: 263,235,000 US dollars
- **Non-current liabilities**: 1,265,064,000 US dollars
- **Equity**: 837,101,000 US dollars
- **Inventories, net**: 306,739,000 US dollars
- **Cash and cash equivalents**: 223,384,000 US dollars
- **Accounts receivable, less allowance for credit losses of $3,618 as of June 27, 2026 and $3,693 as of March 28, 2026**: 216,071,000 US dollars
- **Prepaid expenses and other current assets**: 64,638,000 US dollars
- **Goodwill**: 656,884,000 US dollars
- **Intangible assets, less accumulated amortization of $374,828 as of June 27, 2026 and $363,763 as of March 28, 2026**: 434,512,000 US dollars
- **Property, plant and equipment, net**: 303,778,000 US dollars
- **Other long-term assets**: 149,960,000 US dollars
- **Deferred tax asset**: 9,434,000 US dollars
- **Other current liabilities**: 163,796,000 US dollars
- **Accounts payable**: 56,338,000 US dollars
- **Accrued payroll and related costs**: 38,145,000 US dollars
- **Notes payable and current maturities of long-term debt**: 4,956,000 US dollars
- **Long-term debt**: 1,169,202,000 US dollars
- **Other long-term liabilities**: 57,171,000 US dollars
- **Deferred tax liability**: 38,691,000 US dollars
- **Additional paid-in capital**: 566,759,000 US dollars
- **Retained earnings**: 311,516,000 US dollars
- **Common stock, $0.01 par value; Authorized — 150,000,000 shares; Issued and outstanding — 45,471,313 shares as of June 27, 2026 and 45,252,667 shares as of March 28, 2026**: 455,000 US dollars
- **Accumulated other comprehensive loss**: negative 41,629,000 US dollars
- **Gross equity (calculated)**: 878,730,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.